Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

Marie Skłodowska-Curie Action · Running

MERIT MEtabolic Reprogramming in viral pathogenesis: From Infection to Therapeutic innovations

Coordinator
Stichting Amsterdam Umc, Netherlands
Runs
1 October 2026 to 30 September 2030
Status
Running
EU funding
€4.6m
Total cost
—
Partners
19 organisations in 9 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101312129

What the project is doing

In the project's own words, from its summary on CORDIS.

The MERIT consortium aims to shift virology from a traditional virus-centric approach to one that better incorporates host biology. The primary objective of the consortium is to understand the complex interplay between viruses and host cells, with a focus on metabolic reprogramming and the long-term consequences of infection. This will be achieved through an interdisciplinary approach that incorporates three methodological pillars, viz., organotypic models (organoids), integrative and spatial omics, and advanced (super-resolution) microscopy.

The organotypic models will serve as miniaturised in vitro models that mimic the human genetic and tissue-specific context, enabling the study of organ-specific processes in viral pathogenesis. Integrative omics will provide a comprehensive understanding of virus-host interactions by combining data from diverse approaches, allowing the dissection of specific mechanisms. Spatial omics will result in the precise localisation of molecular changes within the tissue architecture.

Advanced microscopy techniques (super-resolution optical microscopy, label-free 3D tomography, autofluorescence microscopy, and Raman microspectroscopy) will bridge the gap between molecular data and cellular-level events, offering unprecedented visualisation of cells in the tissue context. By integrating these state-of-the-art techniques, the consortium will not only advance fundamental virology research but also contribute to the development of novel therapeutic strategies that address both immediate and long-term impacts of infections.

The research's relevance to the MSCA doctoral programme lies in its innovative training approach, which aims to equip researchers with cutting-edge skills to address emerging infectious diseases. The MERIT researchers will take a more holistic approach to virology, thereby ensuring pandemic preparedness and elevating the EU's position in this field.

Topics

Who is involved

OrganisationCityCountryRole
Stichting Amsterdam UmcAmsterdamNetherlandsCoordinator
Medizinische Universitat InnsbruckInnsbruckAustriaParticipant
Justus-Liebig-Universitaet GiessenGiessenGermanyParticipant
Beonchip SLZaragozaSpainAssociatedpartner
International Centre for Genetic Engineering and BiotechnologyTriesteItalyAssociatedpartner
Academisch Ziekenhuis LeidenLeidenNetherlandsParticipant
Isogen Life Science BVDe MeernNetherlandsAssociatedpartner
Stichting Proefdiervrij* Dutch Society for the Replacement of Animal TestingDen HaagNetherlandsAssociatedpartner
Stichting SaxionEnschedeNetherlandsAssociatedpartner
The Parfum AgencyAmsterdamNetherlandsAssociatedpartner
Universiteit Van AmsterdamAmsterdamNetherlandsAssociatedpartner
Vectory B.V.AmsterdamNetherlandsAssociatedpartner
Chip Nanoimaging ASTromsNorwayAssociatedpartner
Sintef ASTrondheimNorwayAssociatedpartner
Universitetet I OsloOsloNorwayParticipant
Universitetet I Tromsoe - Norges Arktiske UniversitetTromsoNorwayAssociatedpartner
Uniwersytet JagiellonskiKrakowPolandParticipant
Karolinska InstitutetStockholmSwedenParticipant
Stemcell Technologies UK LtdCambridgeUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI